Abstract
Neurogenic bladder (NGB) is an encompassing term that includes multiple causes of bladder dysfunction linked to a congenital or acquired neurological condition that adversely impacts the innervation of the lower urinary tract. Multiple static or progressive conditions can be associated with NGB in pediatric and adolescent patients. Currently, spinal dysraphism (i.e., spina bifida) is one of the most common etiologies, which occurs in 3–4 per 10,000 live births in developed nations. Abnormal bladder dynamics can lead to kidney damage secondary to high pressures or recurrent infections, as well as urinary incontinence. The current management paradigm centers on a proactive approach to preserving kidney function and achieving continence through behavioral, pharmacological, and surgical means. This educational review highlights the key components of urological management to maximize collaboration with pediatric nephrologists.
Similar content being viewed by others
Change history
06 September 2023
A Correction to this paper has been published: https://doi.org/10.1007/s00467-023-06141-3
References
Mai CT, Isenburg JL, Canfield MA et al (2019) National population-based estimates for major birth defects, 2010–2014. Birth Defects Res 111:1420–1435. https://doi.org/10.1002/bdr2.1589
Bauer SB (2008) Neurogenic bladder: etiology and assessment. Pediatr Nephrol 23:541–551. https://doi.org/10.1007/s00467-008-0764-7
Bauer SB (2017) The Hinman Syndrome. J Urol 197(2S):S132–S133. https://doi.org/10.1016/j.juro.2016.11.026
Reid LB, Rose SE, Boyd RN (2015) Rehabilitation and neuroplasticity in children with unilateral cerebral palsy. Nat Rev Neurol 11:390–400. https://doi.org/10.1038/nrneurol.2015.97
Woodhouse CRJ (2008) Myelomeningocele: neglected aspects. Pediatr Nephrol 23:1223–1231. https://doi.org/10.1007/s00467-007-0663-3
Spina Bifida Association (2018) Guidelines for the care of people with spina bifida. https://www.spinabifidaassociation.org/guidelines/
Fairchild RJ, Aksenov LI, Hobbs KT et al (2022) Medical management of neurogenic bladder in patients with spina bifida: a scoping review. J Pediatr Urol 19:55–63. https://doi.org/10.1016/j.jpurol.2022.10.016
Elzeneini W, Waly R, Marshall D, Bailie A (2019) Early start of clean intermittent catheterization versus expectant management in children with spina bifida. J Pediatr Surg 54:322–325. https://doi.org/10.1016/j.jpedsurg.2018.10.096
Dik P, Klijn AJ, van Gool JD et al (2006) Early start to therapy preserves kidney function in spina bifida patients. Eur Urol 49:908–913. https://doi.org/10.1016/j.eururo.2005.12.056
Lapides J, Diokno AC, Silber SJ, Lowe BS (1972) Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol 107:458–461. https://doi.org/10.1016/S0022-5347(17)61055-3
Glinianaia SV, Morris JK, Best KE et al (2020) Long-term survival of children born with congenital anomalies: a systematic review and meta-analysis of population-based studies. PLoS Med 17:e1003356. https://doi.org/10.1371/journal.pmed.1003356
Church PT, Castillo H, Castillo J et al (2020) Prenatal counseling: guidelines for the care of people with spina bifida. J Pediatr Rehabil Med 13:461–466. https://doi.org/10.3233/PRM-200735
Douglas Wilson R, Van Mieghem T, Langlois S, Church P (2021) Guideline no. 410: prevention, screening, diagnosis, and pregnancy management for fetal neural tube defects. J Obstet Gynaecol Can 43:124-139.e8. https://doi.org/10.1016/j.jogc.2020.11.003
Adzick NS, Thom EA, Spong CY et al (2011) A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 364:993–1004. https://doi.org/10.1056/NEJMoa1014379
Mazzone L, Hölscher AC, Moehrlen U et al (2020) Urological outcome after fetal spina bifida repair: data from the Zurich cohort. Fetal Diagn Ther 47:882–888. https://doi.org/10.1159/000509392
Brock JW, Thomas JC, Baskin LS et al (2019) Effect of prenatal repair of myelomeningocele on urological outcomes at school age. J Urol 202:812–818. https://doi.org/10.1097/JU.0000000000000334
Horst M, Mazzone L, Schraner T et al (2017) Prenatal myelomeningocele repair: do bladders better? Neurourol Urodyn 36:1651–1658. https://doi.org/10.1002/nau.23174
Joseph DB, Baum MA, Tanaka ST et al (2020) Urologic guidelines for the care and management of people with spina bifida. J Pediatr Rehabil Med 13:479–489. https://doi.org/10.3233/PRM-200712
Thibadeau J, Walker WO, Castillo J et al (2020) Philosophy of care delivery for spina bifida. Disabil Health J 13:100883. https://doi.org/10.1016/j.dhjo.2019.100883
Sager C, Burek C, Gomez YR et al (2022) Nephro-urological outcomes of a proactive management of children with spina bifida in their first 5 Years of life. J Pediatr Urol 18:181.e1-181.e7. https://doi.org/10.1016/j.jpurol.2021.12.002
Stein R, Bogaert G, Dogan HS et al (2020) EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part I diagnostics and conservative treatment. Neurourol Urodyn 39:45–57. https://doi.org/10.1002/nau.24211
Shlobin NA, Yerkes EB, Swaroop VT et al (2022) Multidisciplinary spina bifida clinic: the Chicago experience. Childs Nerv Syst 38:1675–1681. https://doi.org/10.1007/s00381-022-05594-5
Prakash R, Puri A, Anand R et al (2017) Predictors of upper tract damage in pediatric neurogenic bladder. J Pediatr Urol 13:503.e1-503.e7. https://doi.org/10.1016/j.jpurol.2017.02.026
Fernbach SK, Maizels M, Conway JJ (1993) Ultrasound grading of hydronephrosis: introduction to the system used by the society for fetal urology. Pediatr Radiol 23:478–480. https://doi.org/10.1007/BF02012459
Nguyen HT, Phelps A, Coley B et al (2022) 2021 update on the urinary tract dilation (UTD) classification system: clarifications, review of the literature, and practical suggestions. Pediatr Radiol 52:740–751. https://doi.org/10.1007/s00247-021-05263-w
Sager C, Burek C, Corbetta JP et al (2017) Initial urological evaluation and management of children with neurogenic bladder due to myelomeningocele. J Pediatr Urol 13:271.e1-271.e5. https://doi.org/10.1016/j.jpurol.2016.12.024
Janssen KM, Kirsch AJ, Crisostomo-Wynne TC et al (2021) Standardized protocol for voiding cystourethrogram: are recommendations being followed? J Pediatr Urol 17:66.e1-66.e6. https://doi.org/10.1016/j.jpurol.2020.10.009
Tanaka ST, Yerkes EB, Routh JC et al (2021) Urodynamic characteristics of neurogenic bladder in newborns with myelomeningocele and refinement of the definition of bladder hostility: findings from the UMPIRE multi-center study. J Pediatr Urol 17:726–732. https://doi.org/10.1016/j.jpurol.2021.04.019
Veenboer PW, Hobbelink MGG, Ruud Bosch JLH et al (2015) Diagnostic accuracy of Tc-99m DMSA scintigraphy and renal ultrasonography for detecting renal scarring and relative function in patients with spinal dysraphism: DMSA-Scintigraphy Versus Ultrasound in Adults With SD. Neurourol Urodyn 34:513–518. https://doi.org/10.1002/nau.22608
Tanaka ST, Paramsothy P, Thibadeau J et al (2019) Baseline urinary tract imaging in infants enrolled in the UMPIRE protocol for children with spina bifida. J Urol 201:1193–1198. https://doi.org/10.1097/JU.0000000000000141
Cascio S, Doyle M, Mc Mahon O, Kelly G (2021) Urinary tract imaging in infants with spina bifida: a selective approach to a baseline DMSA. J Pediatr Urol 17:396.e1-396.e6. https://doi.org/10.1016/j.jpurol.2021.02.004
Sarikaya I, Sarikaya A (2019) Current status of radionuclide renal cortical imaging in pyelonephritis. J Nucl Med Technol 47:309–312. https://doi.org/10.2967/jnmt.119.227942
Yadav P, Alsabban A, de Los RT et al (2022) A systematic review of paediatric neurogenic lower urinary tract dysfunction guidelines using the Appraisal of Guidelines and Research Evaluation (AGREE) II instrument. BJU Int 131:520–529. https://doi.org/10.1111/bju.15902
Kavanagh A, Baverstock R, Campeau L et al (2019) Canadian urological association guideline: diagnosis, management, and surveillance of neurogenic lower urinary tract dysfunction. Can Urol Assoc J 13:E157–E176. https://doi.org/10.5489/cuaj.5912
Rawashdeh YF, Austin P, Siggaard C et al (2012) International children’s continence society’s recommendations for therapeutic intervention in congenital neuropathic bladder and bowel dysfunction in children: ICCS: therapeutic Intervention in Pediatric NBD. Neurourol Urodyn 31:615–620. https://doi.org/10.1002/nau.22248
Elliott CS, Dallas K, Shem K, Crew J (2022) Adoption of single-use clean intermittent catheterization policies does not appear to affect genitourinary outcomes in a large spinal cord injury cohort. J Urol 208:1055–1074. https://doi.org/10.1097/JU.0000000000002836
Madero-Morales PA, Robles-Torres JI, Vizcarra-Mata G et al (2019) Randomized clinical trial using sterile single use and reused polyvinylchloride catheters for intermittent catheterization with a clean technique in spina bifida cases: short-term urinary tract infection outcomes. J Urol 202:153–158. https://doi.org/10.1097/JU.0000000000000244
Ye D, Chen Y, Jian Z et al (2021) Catheters for intermittent catheterization: a systematic review and network meta-analysis. Spinal Cord 59:587–595. https://doi.org/10.1038/s41393-021-00620-w
Christison K, Walter M, Wyndaele J-JJM et al (2018) Intermittent catheterization: the devil is in the details. J Neurotrauma 35:985–989. https://doi.org/10.1089/neu.2017.5413
Ben-David R, Carroll F, Kornitzer E et al (2022) Asymptomatic bacteriuria and antibiotic resistance profile in children with neurogenic bladder who require clean intermittent catheterization. Spinal Cord 60:256–260. https://doi.org/10.1038/s41393-021-00679-5
Szymanski KM (2021) Is antibiotic prophylaxis really necessary for infants with neuropathic bladder? J Urol 206:13–14. https://doi.org/10.1097/JU.0000000000001818
Zegers SHJ, Dieleman J, van der Bruggen T et al (2017) The influence of antibiotic prophylaxis on bacterial resistance in urinary tract infections in children with spina bifida. BMC Infect Dis 17:63. https://doi.org/10.1186/s12879-016-2166-y
Andretta E, Longo R, Balladelli M et al (2022) Intravesical gentamicin: an option for therapy and prophylaxis against recurrent UTIs and resistant bacteria in neurogenic bladder patients on intermittent catheterization. Antibiotics 11:1335. https://doi.org/10.3390/antibiotics11101335
Lazarus J (2009) Intravesical oxybutynin in the pediatric neurogenic bladder. Nat Rev Urol 6:671–674. https://doi.org/10.1038/nrurol.2009.214
Franco I, Hoebeke P, Baka-Ostrowska M et al (2020) Long-term efficacy and safety of solifenacin in pediatric patients aged 6 months to 18 years with neurogenic detrusor overactivity: results from two phase 3 prospective open-label studies. J Pediatr Urol 16:180.e1-180.e8. https://doi.org/10.1016/j.jpurol.2019.12.012
US Food and Drug Administration (2020) FDA approves first treatment for a form of bladder dysfunction in pediatric patients as young as 2 years of age. https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-form-bladder-dysfunction-pediatric-patients-young-2-years-age
Sager C, Sanmartino M, Burek C et al (2020) Efficacy and safety of Mirabegron as adjuvant treatment in children with refractory neurogenic bladder dysfunction. J Pediatr Urol 16:655.e1-655.e6. https://doi.org/10.1016/j.jpurol.2020.07.020
US Food and Drug Administration (2021) FDA approves new indication for drug to treat neurogenic detrusor overactivity in pediatric patients. https://www.fda.gov/news-events/press-announcements/fda-approves-new-indication-drug-treat-neurogenic-detrusor-overactivity-pediatric-patients#:~:text=Today%2C%20the%20U.S.%20Food%20and,neurological%20impairment%2C%20in%20children%20ages
Lucas E (2019) Medical management of neurogenic bladder for children and adults: a review. Top Spinal Cord Inj Rehabil 25:195–204. https://doi.org/10.1310/sci2503-195
Moussa M, Papatsoris AG, Abou Chakra M et al (2021) Perspectives on urological care in spina bifida patients. Intractable Rare Dis Res 10:1–10. https://doi.org/10.5582/irdr.2020.03077
Stein R, Bogaert G, Dogan HS et al (2020) EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part II operative management. Neurourol Urodyn 39:498–506. https://doi.org/10.1002/nau.24248
Bowen DK, Meyer T, Rosoklija I et al (2022) Botulinum toxin in patients at-risk for bladder augmentation: durable impact or kicking the can? Neurourol Urodyn 41:1406–1413. https://doi.org/10.1002/nau.24962
Kao Y-L, Huang K-H, Kuo H-C, Ou Y-C (2019) The therapeutic effects and pathophysiology of botulinum toxin A on voiding dysfunction due to urethral sphincter dysfunction. Toxins 11:728. https://doi.org/10.3390/toxins11120728
Overland MR, Leva NV, DiSandro M, Copp HL (2022) Feasibility of awake intravesical botulinum toxin injection in pediatric neurogenic bladder. J Urol 208:702–710. https://doi.org/10.1097/JU.0000000000002709
Roth JD, Cain MP (2018) Neuropathic bladder and augmentation cystoplasty. Urol Clin North Am 45:571–585. https://doi.org/10.1016/j.ucl.2018.06.005
Eldred-Evans D, Khan F, Abbaraju J, Sriprasad S (2015) An unrecognised case of metabolic acidosis following neobladder augmentation cystoplasty. Int J Surg Case Rep 11:129–131. https://doi.org/10.1016/j.ijscr.2015.03.039
Wang X, Zhang F, Liao L (2021) Current applications and future directions of bioengineering approaches for bladder augmentation and reconstruction. Front Surg 8:664404. https://doi.org/10.3389/fsurg.2021.664404
Farrugia M-K, Malone PS (2010) Educational article: the Mitrofanoff procedure. J Pediatr Urol 6:330–337. https://doi.org/10.1016/j.jpurol.2010.01.015
Chavarriaga J, Fernández N, Campo MAO et al (2020) Self-perception, quality of life and ease of catheterization in patients with continent urinary diversion with the mitrofanoff principle. Int Braz J Urol 46:743–751. https://doi.org/10.1590/s1677-5538.ibju.2019.0388
Beierwaltes P, Church P, Gordon T, Ambartsumyan L (2020) Bowel function and care: guidelines for the care of people with spina bifida. J Pediatr Rehabil Med 13:491–498. https://doi.org/10.3233/PRM-200724
Ambartsumyan L, Rodriguez L (2018) Bowel management in children with spina bifida. J Pediatr Rehabil Med 11:293–301. https://doi.org/10.3233/PRM-170533
Szymanski KM, Szymanski AJ, Salama AK et al (2020) Estimating and tracking renal function in children and adults with spina bifida. J Pediatr Urol 16:169–177. https://doi.org/10.1016/j.jpurol.2019.12.009
Zhou G, Jiang M, Liu X et al (2022) Measurement and estimation of glomerular filtration rate in children with neurogenic bladder: a prospective study. Urology 170:174–178. https://doi.org/10.1016/j.urology.2022.08.004
Stepanczuk BC, Dicianno BE, Webb TS (2014) Young adults with spina bifida may have higher occurrence of prehypertension and hypertension. Am J Phys Med Rehabil 93:200–206. https://doi.org/10.1097/PHM.0b013e3182a92b03
Mazur L, Lacy B, Wilsford L (2011) The prevalence of hypertension in children with spina bifida: spina bifida and hypertension. Acta Paediatr 100:e80–e83. https://doi.org/10.1111/j.1651-2227.2011.02225.x
Ramachandra P, Palazzi KL, Holmes NM, Chiang G (2014) Children with spinal abnormalities have an increased health burden from upper tract urolithiasis. Urology 83:1378–1382. https://doi.org/10.1016/j.urology.2013.12.050
Salama AK, Misseri R, Hollowell N et al (2021) Incidence of nephrolithiasis after bladder augmentation in people with spina bifida. J Pediatr Urol 17:521.e1-521.e7. https://doi.org/10.1016/j.jpurol.2021.03.012
Ekberlİ G, Taner S (2023) Risk determination for upper urinary tract damage in children with neuropathic bladder. J Paediatr Child Health. https://doi.org/10.1111/jpc.16402
Bagińska J, Korzeniecka-Kozerska A (2021) Non-invasive markers in the management of pediatric neurogenic bladder over the last two decades – a review. Adv Med Sci 66:162–169. https://doi.org/10.1016/j.advms.2021.02.001
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Answers: B, D, D, C, B.
The original online version of this article was revised: In the Multiple Choice Questions section, the questions and answers were corrected in their assignment.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Brownrigg, N., Lorenzo, A.J., Rickard, M. et al. The urological evaluation and management of neurogenic bladder in children and adolescents—what every pediatric nephrologist needs to know. Pediatr Nephrol 39, 409–421 (2024). https://doi.org/10.1007/s00467-023-06064-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-023-06064-z